InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Heffron Nicola, Chief Executive Officer. Director active across 1 company, notably 2seventy bio, Inc.. In total, 9 disclosures have been published. Split: 0 buy · 7 sells. Total volume traded: €129k. Activity tracked since 11 November 2021. The latest transaction was filed on 7 February 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
60 shares@ US$14.700.6% of flowCommon StockSEC:0001562180-23-001182:0
128 shares@ US$10.62810.9% of flowCommon StockSEC:0001562180-23-000484:0
584 shares@ US$10.33474.0% of flowCommon StockSEC:0001562180-23-000358:0
272 shares@ US$15.43282.8% of flowCommon StockSEC:0001562180-22-008110:0
7,697 shares@ US$13.9773.0% of flowCommon StockSEC:0001562180-22-007877:0
42,500 shares0Common StockSEC:0001562180-22-003847:0
467 shares@ US$15.413923.5% of flowCommon StockSEC:0001562180-22-001227:0
257 shares@ US$31.06126.5% of flowCommon StockSEC:0001885058-21-000003:0
2,953 shares0Common StockSEC:0001628280-21-023468:0
9 of 9 declarations
About Heffron Nicola
Nicola Heffron is the Chief Operating Officer at 2seventy bio, Inc. She is responsible for the company's operations and the implementation of its strategy. 2seventy bio, Inc. is a biopharmaceutical company specializing in developing innovative therapies.
